Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
October 01, 2019     Contact    
 
 >
Paringa Resources (NASDAQ: PNRL) Commences Coal Sales to Second Customer
 

 

Paringa Resources (NASDAQ: PNRL), which operates the low-cost, high-quality Poplar Grove coal mine in western Kentucky, commenced coal sales to Indiana-Kentucky Electric, a wholly owned subsidiary of Ohio Valley Electric (OVEC-IKEC). American Electric Power, a $46 billion energy company, procured the coal on behalf of OVEC-IKEC.

 

Why It Matters: PNRL continues to ramp up sales to its cornerstone customer Louisville Gas and Electric Company and Kentucky Utilities Company (LG&E and KU), with August shipping rates to LG&E and KU of approximately 700 Ktpa on an annualized basis. PRNL also maintains a strong pipeline of forward sales, with ~100% of 2019, ~75% of 2020 and ~50% of the next 5 years' production pre-sold, and the company is making progress with a wide range of customers for additional coal sales contracts for deliveries from 2020 onwards.

 

The Backstory: PNRL operates the low cost, high quality Poplar Grove Mine, part of the Buck Creek Complex located in the Illinois Coal Basin in western Kentucky. The Buck Creek Complex includes two thermal coal mines: (1) the operating Poplar Grove Mine with production capacity ramping up to 2.8 Mtpa; and (2) the permitted Cypress Mine with planned production capacity of 3.8 Mtpa. Construction of the Poplar Grove Mine has been completed and production ramp-up is underway. The Company also has plans to develop the Cypress Mine. Western Kentucky is one of the world’s best mining jurisdictions due to its access to low cost power, utilities, transportation and a non-union labor pool. Mining conditions at Poplar Grove are similar to those in neighboring mines, which rank as some of the world’s most productive room-and-pillar operations.

 

Disclosure

Paringa Resources Limited (NASDAQ: PNRL) is a client of RedChip Companies, Inc. PNRL agreed to pay RedChip Companies, Inc., a monthly cash fee for RedChip investor awareness services.

 
 
 
 >
Medalist Diversified REIT (NASDAQ: MDRR) Completes Acquisition of Clemson Best Western
 

 

Medalist Diversified REIT (NASDAQ: MDRR), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Southeast region of the U.S., completed the acquisition of the Clemson Best Western, a 148 room hotel which includes a restaurant, bar and conference facility. The hotel, located in Clemson, South Carolina, was purchased for $9,750,000.

 

Why It Matters: The hotel is located less than a mile from Clemson University, with a student enrollment of 24,500 and over 5,000 faculty members. The student population is expected to increase in the coming years, and the athletic programs at Clemson University continue to attract visitors year-round.

 

Key Quote: “We believe this is an attractive property and well located near the university. With the additional revenue generators available including the restaurant (The Alumni Restaurant), bar and conference space, we expect ownership of the property to be very accretive to the REIT.” – Tim Messier, Chairman & CEO

 

The Backstory: MDRR’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. The company utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions and seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the southeast for acquisition opportunities and disposal of properties as considered appropriate. Since going public in November 2018, MDRR has declared three quarterly dividends of $0.175 each.

 

Disclosure

Medalist Diversified REIT (MDRR) is a client of RedChip Companies, Inc. MDRR agreed to pay RedChip Companies, Inc. a monthly cash fee for four (4) months of RedChip investor awareness services.

 
 
 
 >
cbdMD (NYSE American: YCBD) Signs Agreement with Veteran Brand Builder Hans Molenkamp
 

 

cbdMD (NYSE American: YCBD) entered into an advisory agreement with Hans Molenkamp, who will hold the title of Vice President of Sports Marketing for the company.

 

Why It Matters: Molenkamp has over 20 years of experience as a senior marketing executive to global brands such as Triumph United and Monster Energy. He has a proven track record of driving business results through innovative campaigns and building high-performance teams. Molenkamp brings a wide variety of skill sets, including brand building, athlete and entertainment management, social media content activation, photography and digital production.

 

Key Quote: “We're excited to have Hans bring his passion and enthusiasm to cbdMD. We expect that his deep and broad experience in brand building will be a valuable asset to cbdMD as we continue to execute our strategic sports marketing blueprint.” – Ken Cohn, Chief Marketing Officer

 

The Backstory: cbdMD is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and the CBD pet product line PawCBD.

 

Disclosure

cbdMD (NYSE American: YCBD) is a client of RedChip Companies. YCBD agreed to pay RedChip a monthly cash fee of between $5,000 and $15,000, and 5,000 shares of Rule 144 stock for RedChip investor awareness services. Additionally, the CEO of RedChip Companies owns 13,500 shares of YCBD.

 
 
 
 >
Catasys (NASDAQ: CATS) Announces $45M Debt Financing Commitment from Goldman Sachs
 

 

Catasys (NASDAQ: CATS), a leading AI and technology-enabled healthcare company, entered into a financing agreement with Goldman Sachs with a committed purchase of up to $45 million of senior secured notes, comprised of a $35 million initial purchase and up to $10 million in additional issuances.

 

Why It Matters: Catasys intends to use the proceeds to retire the Company’s existing credit facilities, continue scaling new contracts and expansions, invest in additional technology enhancements, develop new products including the Catasys PRE™ platform, and provide excess capital for growth.

 

Key Quote: “Our leadership team worked closely with Goldman Sachs over the past few months and are thrilled to have the bank as a new financing provider, which may result in future funding commitments. Given current and anticipated growth of eligible members of our outreach pool, we anticipate the proceeds from this financing will enable Catasys to achieve positive cash flow as we continue working to execute on our program and platform expansions and technological advancements in the remainder of 2019 and beyond.” – Terren Peizer, Chairman & CEO

 

The Backstory: CATS is a leading AI and technology-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Its Catasys PRETM (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who aren’t getting the care they need. By combining predictive analytics with human engagement, CATS delivers improved member health and validated outcomes and savings to healthcare payers. The company’s integrated, technology-enabled OnTrak solution, a critical component of the Catasys PRE platform, is designed to treat members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.

 

Disclosure

Catasys (NASDAQ: CATS) is a client of RedChip Companies, Inc. CATS agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.

 
 
 
 >
CTD Holdings (OTCQB: CTDH) Announces New Collaboration to Advance Alzheimer’s Study
 

 

CTD Holdings (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced a new collaboration with the Chattanooga Center for Neurologic Research (CCNR) based in Chattanooga, TN.

 

Why It Matters: CCNR is a biomedical research company led by globally recognized vascular neurologist, Dr. Thomas Devlin. In close partnership with Erlanger Health System and the University of Tennessee College of Medicine, Dr. Devlin has spearheaded the launch of various biotech companies whose commercialized products are having widespread impact on neurologic disease. The collaboration is expected to lead to selection of CCNR and the Erlanger Health System as a site in CTDH’s clinical trial in Alzheimer’s Disease, now in the design stage. As a first step in the collaboration, CCNR and CTD representatives will exchange confidential information on priority scientific topics and clinical capacity.

 

Key Quote: “Given the significant overlap between stroke, dementia, and Alzheimer’s disease, we are delighted to undertake this collaboration with Dr. Devlin and his team as we build our respective Alzheimer’s programs. Dr. Devlin’s expertise as a world-class clinical researcher in neurovascular disease and stroke is directly applicable as we build out the CTD Alzheimer’s platform.” - Scott Fine, Chairman & CEO

 

The Backstory: CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is in three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, and in an Expanded Access program for late-onset Alzheimer’s Disease.

 

Disclosure

CTD Holdings (OTCQB: CTDH) is a client of RedChip Companies, Inc. CTDH agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.

 
 
 
 >
Digital Ally (NASDAQ: DGLY) Signs Contract Extension with Major Cruise Line
 

 

Digital Ally (NASDAQ: DGLY), which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, announced a contract extension with a global leader in the cruise line industry for their continued use of the Company’s FirstVu HD body-worn cameras and back-office solution, VuVault.com.

 

Why It Matters: The contract extension will provide DGLY with a recurring service revenue stream for multiple years to come. Since 2016, the company’s FirstVu HD body-worn cameras have been deployed on security personnel during cruises to reduce frivolous claims and capture interactions between staff and guests. The contract extension demonstrates the effectiveness of the body-worn camera in de-escalating situations.

 

Key Quote: “This contract extension continues the commitment of safety and security for all staff members and guests aboard the cruise line.” – Stan Ross, CEO

 

The Backstory: DGLY specializes in the design and manufacture of the highest quality video recording equipment and video analytic software. The company pushes the boundaries of technology in industries such as law enforcement, emergency management, fleet safety and security. DGLY’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology, and its products are sold by domestic direct sales representatives and international distributors worldwide.

 

Disclosure

Digital Ally, Inc. (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.

 
 
 
 >
SinglePoint (OTCQB: SING) Sees Strong Early Success for Pure Hemp Cigarettes
 

 

SinglePoint (OTCQB: SING) announced last week that its hemp cigarette marketing strategy for Pure American Hemp Cigarettes, which includes direct mail, email and social media, is enjoying significant early success.

 

Why It Matters: The company has already received orders and scheduled multiple meetings with buyers and distributors for the upcoming 2019 National Association of Convenience Stores (NACS) event. The NACS Show attracts more than 23,500 industry stakeholders from around the world, bringing together buyers and sellers to conduct business and learn from one another.

 

Key Quote: “We believe Pure Hemp cigarettes are going to be a huge success for us and we are excited to launch this product at the largest, most respected show in the industry. There has been major traction with the marketing we have put into this campaign. The opportunity to be leading the hemp cigarette market is right in front of us. Previously I pioneered a related product (Premium Cigars) that culminated in opening nearly 30,000 retail accounts. This product has the same potential. It’s the right product at the right time in the right place. We are set up and ready to take orders at the show.” - Greg Lambrecht, CEO

 

Disclosure

SinglePoint, Inc. (OTCQB: SING) is a client of RedChip Companies, Inc. SING agreed to pay RedChip Companies, Inc. a monthly cash fee for RedChip investor awareness services and consulting services.

 
 
 
 >
ChineseInvestors.com (OTC: CIIX) Announces Expansion of CBD Biotech
 

 

ChineseInvestors.com (OTC: CIIX), a premier provider of financial news and education for the Chinese-speaking community, announced that its CBD Biotech subsidiary has expanded into six new countries and a new region of China via its newest sales channel, Shopee, a popular Singaporean e-commerce platform.

 

Why It Matters: Launched in 2015, Shopee is now the largest e-commerce platform in Southeast Asia with more than 4 million registered businesses, 200 million app downloads, 30 million social media fans over 7 million active buyers. According to Google and Temasek's Southeast Asia Internet Economy Report, by 2025, Southeast Asia's e-commerce market is expected to reach $240 billion. According to the latest report by App Annie, iPrice Group and Similar Web, in the second quarter of 2019, Shopee ranked first in terms of active users (MAU), desktop and mobile network visits and total downloads among the APP shopping category in Southeast Asia.

 

Key Quote: “This dynamic and very popular platform in Southeast Asia, has allowed CBD Biotech to execute on our plans for expansion throughout Asia. Thanks to Shopee, we are now in seven new major markets: Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines and Taiwan, China.” - Alex Hamilton, CFO

 

Disclosure

ChineseInvestors.com, Inc. (OTCQB: CIIX) is a client of RedChip Companies. CIIX pays RedChip a monthly cash fee for twelve (12) months of investor awareness services.

 
 
 
 
 
Upcoming Events
 
 >
Learn About Can-Fite BioPharma (NYSE American: CANF) on Exclusive Group Call This Wednesday
 

 

Join Dr. Pnina Fishman, CEO of Can-Fite BioPharma (NYSE American: CANF), for a 15-minute presentation and live Q&A session this Wednesday, October 2, to learn about recent developments and key upcoming milestones for this exciting advanced clinical stage drug development company.

 

Call information:

Oct. 2 at 4 pm ET /1 pm PT

Conference Line: (866) 821-0302**

**U.S. only. Contact us at info@redchip.com for dial-in info for investors outside U.S.

 

The Background: CANF has a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, as well as liver diseases including advanced liver cancer and NASH. CANF’s drugs have an excellent safety profile with experience in over 1,000 patients. The company’s intellectual property portfolio consists of 13 patent families issued and pending. Piclidenoson and Namodenoson have been out-licensed in select territories with approximately $18 million received to date.

 

Disclosure

Can-Fite Biopharma (NYSE American: CANF) is a client of RedChip Companies, Inc. CANF agreed to pay RedChip Companies, Inc. a monthly cash fee for 12 months of RedChip investor awareness services and consulting services. RedChip Companies also owns 16,500 shares of CANF Rule 144 stock, acquired in August 2019.

 
 
 
 >
Learn About Piedmont Lithium (NASDAQ: PLL) at Next Week’s Investor Webinar
 

 

Piedmont Lithium (NASDAQ: PLL) President and CEO Keith Phillips will give a presentation and be available during a live Q&A session next Tuesday, October 8, to discuss recent developments at the company, including new data published in recent months regarding resource estimates and updated scoping study.

 

Webinar Information:

Oct. 8 at 11 am ET /8 am PT

Location: www.redchip.com/corporate/webinar_register/48

 

The Background: PLL holds a 100% interest in the Piedmont Lithium Project located within the Carolina Tin-Spodumene Belt (TSB) and along trend to the Hallman Beam and Kings Mountain mines, which historically provided most of the western world’s lithium between the 1950s and the 1980s. The TSB has been described as one of the largest lithium regions in the world and is located approximately 25 miles west of Charlotte, North Carolina.

 

Disclosure

Piedmont Lithium (NASDAQ: PLL) is a client of RedChip Companies, Inc. PLL agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.

 
 
 
 
Quote of the Week
 
"It’s harder and always takes longer than you anticipate."
-Manny Villafana, Founder of St. Jude Medical
 
 
 
Lesson of the Week
 
Read an interesting perspective on liquidity from leading small-cap manager, Michael Corbett at Perritt Capital.
Read More
 
 
 
 
Latest Videos
 
 
 
 
3 Small-Cap Stocks with Strong Revenue Growth
 
Watch our exclusive interviews with executives from three exciting small-cap companies: Immuron Ltd. (NASDAQ: IMRN), SG Blocks (NASDAQ: SGBX), and SinglePoint (OTCQB: SING).
 
Watch Now
 
 
 
 
Interview with SPI Energy CFO Anthony Chan
 
Watch our exclusive interview with SPI Energy (NASDAQ: SPI) CFO Anthony Chan. SPI is an established green energy player with global operations in key markets in Australia, Europe, Japan, and the United States. It is leveraging its solar platform and industry expertise to make strategic investment opportunities in green industries with significant growth and earnings potential and/or industries than can benefit from green power.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Clinical Stage Drug Development Company with Target Price of $9.00
 
Watch our exclusive interview with Dr. Pnina Fishman, CEO of Can-Fite BioPharma Ltd. (NYSE American: CANF), an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases including advanced liver cancer and NASH.
 
Watch Now
 
 
 
 
Overview: High-Growth Solar & CBD Company
 
SinglePoint, Inc (OTCQB: SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services, solar, and blockchain solutions.
 
Watch Now
 
 
 
 
Can-Fite BioPharma Positioned for Upside
 
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases including advanced liver cancer and NASH.Dawson James rates CANF a buy with a price target of $9 per share.
 
Watch Now
 
 
 
 
Digital Ally (NASDAQ: DGLY): Global Leader in Body-Cam Technology
 
Digital Ally (NASDAQ: DGLY), headquartered in Lenexa, KS, specializes in the design and manufacturing of the highest quality video recording equipment and video analytic software.
 
Watch Now
 
 
 
 
Interview with iSIGN CEO Philip Sassower
 
iSIGN (OTC: ISGN) is a leading provider of digital transaction management (DTM) software enabling fully digital (paperless) business processes. iSIGN’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication.
 
Watch Now
 
 
 
 
GSRX Industries: High-Growth Retailer in Multi-Billion-Dollar Market
 
GSRX Industries (OTCQB: GSRX) is led by CEO Les Ball, former Chairman of Macy’s Midwest and President of Macy’s East. The company has built a portfolio of retail and manufacturing assets and is realizing growth in all aspects of its operations.
 
Watch Now
 
 
 
 
Interview with CEO of Only Traditional Lithium Development Project in US
 
Watch our exclusive interview with Keith Phillips, CEO of Piedmont Lithium (NASDAQ: PLL), who discusses the company's development of the only traditional lithium project in the US.
 
Watch Now
 
 
 
 
Could CTD Holdings (OTCQB: CTDH) have a Treatment for Alzheimers?
 
CTD Holdings (OTCQB: CTDH) was authorized by the FDA to use Trappsol® Cyclo™ for a late-onset Alzheimer’s Disease (AD) patient under a Compassionate Use Program which began intravenous dosing in May 2018.
 
Watch Now
 
 
 
 
Introducing Piedmont Lithium: Positioned for Big Upside
 
Piedmont Lithium Ltd. (Nasdaq: PLL) holds a 100% interest in the Piedmont Lithium Project (“Project”) located within the world-class Carolina Tin-Spodumene Belt (“TSB”) and along trend to the Hallman Beam and Kings Mountain mines, historically providing most of the western world’s lithium between the 1950s and the 1980s.
 
Watch Now
 
 
 
 
Medalist Diversified REIT (NASDAQ: MDRR): Strong Dividend Track Record, Targeting Markets in Southeastern US
 
Medalist Diversified REIT (NASDAQ: MDRR) is a dvidend-paying, Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Southeastern US.
 
Watch Now
 
 
 
 
CTD Holdings: Clinical-Stage Biotech Targeting Alzheimer's and Other Unmet Medical Needs
 
Watch our exclusive interview with Scott Fine, Chairman and CEO of CTD Holdings (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
The FANG stocks declined 3.8% for the week as value stocks continued to outperform growth stocks.
Read More
 
 
Weekly Index Performance
 
Markets were lower last week, led by tech and microcaps.
Read More
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.